Imunon Inc (IMNN)
1.18
+0.05
(+4.42%)
USD |
NASDAQ |
Jun 28, 16:00
1.19
+0.01
(+0.85%)
After-Hours: 07:21
Imunon SG&A Expense (TTM): 8.396M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 8.396M |
December 31, 2023 | 9.743M |
September 30, 2023 | 11.38M |
June 30, 2023 | 13.34M |
March 31, 2023 | 13.88M |
December 31, 2022 | 13.69M |
September 30, 2022 | 12.27M |
June 30, 2022 | 11.10M |
March 31, 2022 | 10.82M |
December 31, 2021 | 10.89M |
September 30, 2021 | 10.37M |
June 30, 2021 | 9.441M |
March 31, 2021 | 8.740M |
December 31, 2020 | 7.642M |
September 30, 2020 | 7.340M |
June 30, 2020 | 7.386M |
March 31, 2020 | 7.621M |
December 31, 2019 | 8.000M |
September 30, 2019 | 8.725M |
June 30, 2019 | 8.846M |
March 31, 2019 | 10.25M |
December 31, 2018 | 9.700M |
September 30, 2018 | 8.766M |
June 30, 2018 | 7.980M |
March 31, 2018 | 6.087M |
Date | Value |
---|---|
December 31, 2017 | 5.890M |
September 30, 2017 | 5.930M |
June 30, 2017 | 6.252M |
March 31, 2017 | 6.132M |
December 31, 2016 | 6.527M |
September 30, 2016 | 6.258M |
June 30, 2016 | 6.245M |
March 31, 2016 | 6.518M |
December 31, 2015 | 6.687M |
September 30, 2015 | 7.395M |
June 30, 2015 | 7.955M |
March 31, 2015 | 8.458M |
December 31, 2014 | 8.860M |
September 30, 2014 | 8.302M |
June 30, 2014 | 7.647M |
March 31, 2014 | 7.292M |
December 31, 2013 | 6.547M |
September 30, 2013 | 6.816M |
June 30, 2013 | 6.846M |
March 31, 2013 | 6.491M |
December 31, 2012 | 6.373M |
September 30, 2012 | 5.835M |
June 30, 2012 | 5.823M |
March 31, 2012 | 5.510M |
December 31, 2011 | 5.155M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
7.340M
Minimum
Sep 2020
13.88M
Maximum
Mar 2023
10.04M
Average
9.743M
Median
Dec 2023
SG&A Expense (TTM) Benchmarks
iBio Inc | 11.84M |
Ocugen Inc | 30.20M |
Avalo Therapeutics Inc | 10.79M |
Petros Pharmaceuticals Inc | 9.842M |
NovaBay Pharmaceuticals Inc | 12.53M |